Identification of two taurine receptor subtypes on the primary afferent terminal of frog spinal cord.
1. Effects of taurine on primary afferent terminals in the frog spinal cord were examined by a sucrose-gap method applied to a dorsal root (9th or 10th segment). 2. In a normal Ringer solution, taurine (1 mM, applied for 5s at a rate of 0.04 ml s-1, 0.2 mumol) caused a hyperpolarization, but a higher concentration (10 mM, applied at the same rate, 2.0 mumol) caused a biphasic response consisting of a hyperpolarization followed by a slow onset depolarization. A similar biphasic response could also be observed in tetrodotoxin-treated preparations. 3. When the concentration of extracellular Mg2+ was increased up to 9.0 mM, the depolarizing response to taurine was augmented. The rate of the augmentation was dependent upon the extracellular Mg2+ concentration. 4. The depolarizing effect was selectively antagonized by bicuculline in concentrations (10-30 microM) that had no significant antagonizing action on gamma-aminobutyric acid (GABA)-induced depolarization. On the other hand the hyperpolarizing effect of taurine was selectively reduced by strychnine (0.1 microM) which had no antagonizing effect on responses to glycine. 5. These results suggest that in the frog spinal cord there are at least two subtypes of taurine receptor whose pharmacological profiles resemble GABA and glycine receptors in the mammalian central nervous system, and whose sensitivity may be modulated by extracellular Mg2+.
Kudo
Y
Y
Department of Neuroscience, Mitsubishi-Kasei Institute of Life Sciences, Tokyo, Japan.
Akiyoshi
E
E
Akagi
H
H
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001640:Bicuculline / Q000494:pharmacology; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D009475:Neurons, Afferent / Q000032:analysis* / Q000187:drug effects / Q000378:metabolism; D011892:Rana catesbeiana; D017981:Receptors, Neurotransmitter / Q000032:analysis*; D013116:Spinal Cord / Q000032:analysis*; D013331:Strychnine / Q000494:pharmacology; D013654:Taurine / Q000378:metabolism / Q000494:pharmacology
D017981:Receptors, Neurotransmitter; C030803:taurine receptor; D013654:Taurine; D013331:Strychnine; D008274:Magnesium; D001640:Bicuculline